Are AI browsers safe? A single web page can hijack an agent working inside your logged-in accounts. Here's how to limit what ...
Hackers are exploiting the "wp2shell" critical vulnerability suite (CVE-2026-63030 and CVE-2026-60137) affecting WordPress ...
As Google incorporates more artificial intelligence into search, people are spending more time on Google. Some website ...
Microsoft has warned that attackers are varying their post-exploitation techniques while relying on the same ClickFix lure, ...
Hosted on MSN
Why Britain's AJAX is more dangerous than it looks
The AJAX is more than just an armored vehicle—it’s a battlefield intelligence platform designed to detect threats, gather real-time information, and help commanders make faster decisions. In this ...
As AI continues to advance, infrastructure must evolve to enable access and delivery of real-time information at scale. In partnership withBright Data AI is booming. New use cases are emerging each ...
Add Yahoo as a preferred source to see more of our stories on Google. The Ajax was seen in its first public running display at Tankfest 2024 at The Tank Museum in Dorset, but problems quickly emerged ...
Trials of the British Army’s Ajax armoured vehicles are set to resume, despite major delays amid concern for soldiers’ safety. Minister for Defence Readiness and Industry Luke Pollard announced in ...
Eli Lilly LLY-2.33%decrease; down pointing triangle continued its recent buying spree, agreeing to pay up to $2.3 billion for Ajax Therapeutics in a deal that bolsters the drugmaker’s blood-cancer ...
Eli Lilly said on Monday it would buy privately held cancer drug developer Ajax Therapeutics for up to $2.3 billion in cash, as the U.S. drugmaker looks to expand its oncology pipeline. Lilly has been ...
April 27 (Reuters) - Eli Lilly (LLY.N), opens new tab said on Monday it would buy privately held cancer drug developer Ajax Therapeutics for up to $2.3 billion in cash, as the U.S. drugmaker looks to ...
Eli Lilly’s run of near-weekly acquisitions still shows no sign of letting up, with the Big Pharma now buying Ajax Therapeutics for its clinical-stage myelofibrosis therapy. At the center of the deal ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results